Cargando…
Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589698/ https://www.ncbi.nlm.nih.gov/pubmed/34805647 http://dx.doi.org/10.1016/j.ekir.2021.09.014 |
| _version_ | 1784598786424700928 |
|---|---|
| author | Zhao, Li-Min Qiu, Mei |
| author_facet | Zhao, Li-Min Qiu, Mei |
| author_sort | Zhao, Li-Min |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8589698 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85896982021-11-19 Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” Zhao, Li-Min Qiu, Mei Kidney Int Rep Letter to the Editor Elsevier 2021-10-07 /pmc/articles/PMC8589698/ /pubmed/34805647 http://dx.doi.org/10.1016/j.ekir.2021.09.014 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Zhao, Li-Min Qiu, Mei Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title | Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title_full | Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title_fullStr | Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title_full_unstemmed | Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title_short | Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR” |
| title_sort | letter regarding “systematic review of cardiovascular outcome trials using new antidiabetic agents in ckd stratified by estimated gfr” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589698/ https://www.ncbi.nlm.nih.gov/pubmed/34805647 http://dx.doi.org/10.1016/j.ekir.2021.09.014 |
| work_keys_str_mv | AT zhaolimin letterregardingsystematicreviewofcardiovascularoutcometrialsusingnewantidiabeticagentsinckdstratifiedbyestimatedgfr AT qiumei letterregardingsystematicreviewofcardiovascularoutcometrialsusingnewantidiabeticagentsinckdstratifiedbyestimatedgfr |